• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Halobenzoic acids and derivatives

Introduction to 2-Fluoro-5-methoxy-benzhydrazide (CAS No. 1167055-59-5)

2-Fluoro-5-methoxy-benzhydrazide, identified by the Chemical Abstracts Service Number (CAS No.) 1167055-59-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the benzhydrazide class, characterized by its benzene ring substituted with a fluoro group at the 2-position and a methoxy group at the 5-position, linked to a hydrazide moiety. The unique structural features of this molecule make it a valuable intermediate in the synthesis of various pharmacologically active agents.

The fluoro and methoxy substituents in 2-Fluoro-5-methoxy-benzhydrazide play crucial roles in modulating its chemical reactivity and biological activity. The fluoro group, known for its ability to enhance metabolic stability and binding affinity, is frequently incorporated into drug molecules to improve their pharmacokinetic properties. On the other hand, the methoxy group contributes to hydrophobicity and can influence the molecule's solubility and interaction with biological targets. These structural elements collectively contribute to the compound's potential as a building block in drug discovery.

In recent years, there has been growing interest in exploring the therapeutic applications of benzhydrazide derivatives. Studies have demonstrated that compounds within this class exhibit a broad spectrum of biological activities, including anti-inflammatory, antiviral, and anticancer properties. The presence of both fluoro and methoxy groups in 2-Fluoro-5-methoxy-benzhydrazide suggests that it may possess enhanced bioactivity compared to its unsubstituted counterparts. This has prompted researchers to investigate its potential as a lead compound or intermediate in the development of novel therapeutic agents.

One of the most compelling aspects of 2-Fluoro-5-methoxy-benzhydrazide is its versatility in synthetic chemistry. The hydrazide functional group provides a reactive site for further derivatization, allowing chemists to modify the molecule's structure and tailor its biological properties. This flexibility has enabled the synthesis of numerous analogs, each with distinct pharmacological profiles. For instance, researchers have explored derivatives of this compound as inhibitors of enzymes involved in cancer progression or as modulators of neurotransmitter receptors.

The pharmaceutical industry has increasingly recognized the importance of fluorinated compounds due to their favorable pharmacokinetic profiles. The fluoro group can improve drug absorption, distribution, metabolism, and excretion (ADME) properties, making it an attractive feature for drug design. 2-Fluoro-5-methoxy-benzhydrazide, with its strategic placement of fluorine, represents an excellent candidate for further exploration in this context. Its potential to enhance drug-like properties while maintaining biological activity makes it a promising candidate for preclinical and clinical development.

Recent advancements in computational chemistry and high-throughput screening have accelerated the process of identifying novel drug candidates. These technologies have enabled researchers to rapidly evaluate the binding affinity and selectivity of various compounds against biological targets. In this regard, 2-Fluoro-5-methoxy-benzhydrazide has been subjected to computational studies to predict its interactions with potential therapeutic targets. Preliminary results suggest that it may exhibit significant binding affinity for certain enzymes and receptors, warranting further experimental validation.

The synthesis of 2-Fluoro-5-methoxy-benzhydrazide involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. The introduction of fluorine at the 2-position and methoxy at the 5-position necessitates careful optimization to ensure high yield and purity. Advances in synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions and fluorination techniques, have made it possible to produce this compound with greater efficiency and scalability. These improvements have opened up new avenues for exploring its pharmaceutical applications.

Given its structural complexity and potential bioactivity, 2-Fluoro-5-methoxy-benzhydrazide has attracted attention from academic researchers and pharmaceutical companies alike. Collaborative efforts between these entities have led to innovative approaches in drug discovery and development. For example, researchers have combined traditional synthetic chemistry with modern biotechnological methods to explore new derivatives of this compound with enhanced therapeutic potential.

The future prospects for 2-Fluoro-5-methoxy-benzhydrazide are promising, with ongoing studies aimed at elucidating its mechanism of action and optimizing its pharmacological properties. As our understanding of disease pathways continues to evolve, so does our ability to design targeted therapies. Compounds like 2-Fluoro-5-methoxy-benzhydrazide, with their unique structural features and versatile reactivity, are poised to play a crucial role in addressing unmet medical needs.

In conclusion,2-Fluoro-5-methoxy-benzhydrazide (CAS No. 1167055-59-5) is a multifaceted compound with significant potential in pharmaceutical research. Its combination of fluoro and methoxy substituents enhances its bioactivity and drug-like properties, making it an attractive candidate for further development. With advancements in synthetic chemistry and computational biology,2-Fluoro-5-methoxy-benzhydrazide is likely to contribute significantly to the discovery and development of novel therapeutic agents in the coming years.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)